Researchers at Johns Hopkins point out that aging alone, not hormonal influence of menopause, causes increased number of death in women
Rebecca Zahau, the girlfriend of the CEO of Medicis Pharmaceutical Corporation, Jonah Shacknai, committed suicide and was not a homicide victim, The San Diego County Sheriff's Department said Friday. Young female athletes who have stopped menstruating have a weakening in the quality of their bone structure that may predispose them to breaking a bone, despite getting plenty of weight-bearing exercise, a new study finds. The results will be presented Sunday at The Endocrine Society's 93rd Annual Meeting in Boston. C.S. Lewis, the famous author and Oxford academic, once proclaimed "You can't get a cup of tea big enough or a book long enough to suit me." We sip it with toast in the morning, enjoy it with sweets and biscuits in the afternoon, and relax with it at the end of the day. Tea has for generations been an integral infusion worldwide, carrying both epicurean and economic significance. But, does it impart honest-to-goodness health benefits? In other words, is its persistence in the human diet perhaps coincident with enhanced quality (or quantity) of life? A new study published in the April 2011 issue of the Journal of the American Dietetic Association indicates that inadequate nutrition is linked to a greater risk of anemia in postmenopausal women.
Obesity is widely believed to be protective against fracture, although a recent study has documented a high prevalence of obesity in postmenopausal women with fragility fracture. A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that higher levels of perfluorocarbons (PFCs) in the body are associated with increased odds of having experienced menopause in women between 42 and 64 years old. Women undertaking post-menopausal hormone therapy are at a higher risk for ovarian cancer, a study by the European Prospective Investigation into Cancer and Nutrition said. Menerba, a new drug to cure menopausal hot flashes by pharmaceutical company Bionovo, Inc has got the US Food and Drug Administration approval stamp on Thursday. The company focuses on discovery and development of women's health and cancer drugs. Women planning on taking hormone therapy for the treatment of menopausal symptoms should be aware of a possible increased risk for ovarian cancer, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010. Follow-up of about 11 years of participants in the Women's Health Initiative finds that among postmenopausal women, use of estrogen plus progestin is associated with an increased incidence of breast cancers that are more advanced, and with a higher risk of deaths attributable to breast cancer, according to a study in the October 20 issue of JAMA. The first research from the Breakthrough Generations Study could lead to a test to predict a woman's reproductive lifespan.